public supply contract (classification CPV: 33651600-4 - vaccines), for the acquisition and supply of vaccines registered in Belgium or under the European centralised procedure, intended to protect children and adolescents against poliomyelitis, diphtheria, pertussis, tetanus, measles, rubella, mumps, hepatitis B, human papillomavirus infections and invasive Haemophilus influenzae B diseases, pneumococcus and meningococcal serogroups A, C, W and Y, as well as pregnant women, for pertussis.

inactivated poliomyelitis vaccine, in connection with the only legal obligation in force in Belgium regarding vaccination, intended for the basic vaccination of infants aged 2 to 15 months or catch-up vaccination of children and adolescents following a 2+1 dose regimen

recombinant hepatitis B vaccine, in adult dose, for catch-up vaccination of adolescents (11-15 years) following a 2-dose schedule

vaccine against human papillomavirus infections, protecting against all cancers for which HPV is involved and against genital warts

tetravalent combination diphtheria, tetanus, pertussis vaccine (acellular vaccine, unreduced doses for DTPa) and poliomyelitis (inactivated vaccine) for booster vaccination of children aged 5 to 6 years on a basic 1-dose schedule, or for catch-up vaccination of children 6 to 11 years of age on a 2+1-dose schedule

Trivalent measles, mumps and rubella vaccine for immunization of infants at 12 months of age and children at 7-8 years of age as well as for catch-up vaccination of adolescents and young adults, following a basic 2-dose schedule

Diphtheria, tetanus and pertussis vaccine for booster vaccination of adolescents from 15 years of age following a basic 1-dose schedule and catch-up vaccination of adolescents from 12 years of age following a 2+1 dose schedule, as well as vaccination of pregnant women following a basic 1-dose schedule

meningococcal conjugate vaccine serogroups A, C, W and Y for the vaccination of infants at 15 months of age and for catch-up vaccination of children up to 2nd primary, following a basic 1-dose schedule

pneumococcal conjugate vaccine, containing at least one component specifically directed directly against serotype 19A, for the vaccination of infants aged 2 to 12 months and for catch-up vaccination of children up to 2 years of age following a basic 2+1-dose schedule

hexavalent combination vaccine against diphtheria, tetanus, pertussis (acellular vaccine), poliomyelitis (inactivated vaccine), hepatitis B and Haemophilus influenzae type B infections for the vaccination of infants aged 2 to 15 months and for catch-up vaccination of children up to 5 years of age, following a basic 3+1-dose schedule